- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Healthcare IT investments reduce operating costs
More than 60% of U.S. hospitals have made significant enough investments in information technology to begin seeing reductions in operating costs, according to a survey by PricewaterhouseCoopers.
More than 60% of U.S. hospitals have made significant enough investments in information technology to begin seeing reductions in operating costs, according to a survey by PricewaterhouseCoopers.
The report covers nearly 2000 U.S. hospitals. It was conducted by PricewaterhouseCoopers and Prof. Lorin Hitt of the Wharton School of University of Pennsylvania. The researchers concluded that IT investment must reach a tipping point before cost-reducing performance improvements occur and that six in 10 hospitals are at or nearing that point.
When hospitals move into high adopter categories, strong evidence suggests IT investments lead to cost reduction as the organization gains skills in leveraging the technology. To fully realize the value from IT investments, organizations must also redesign clinical and business processes.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
